The positive effect of sildenafil on LUTS from BPH while treating ED.
- Author:
Jun YING
1
;
Dehong YAO
;
Yueqing JIANG
;
Xiaomin REN
;
Mingxi XU
Author Information
- Publication Type:Journal Article
- MeSH: Aged; Erectile Dysfunction; drug therapy; Follow-Up Studies; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; therapeutic use; Piperazines; therapeutic use; Prostatic Hyperplasia; complications; Purines; therapeutic use; Sildenafil Citrate; Sulfones; therapeutic use; Surveys and Questionnaires; Urination Disorders; drug therapy; etiology
- From:National Journal of Andrology 2004;10(9):681-683
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore the possible relationship between erectile dysfunction (ED) and benign prostate hyperplasia (BPH) in men, and to assess the positive effect of Sildenafil on the lower urinary tract symptoms (LUTS) from BPH while treating ED.
METHODSThirty-two patients with ED and BPH were offered oral Sildenafil and reviewed before and six months after the administration of Sildenafil by the International Index of Erectile Function-5 (IIEF-5) and the International Prostate Symptom Score (IPSS) questionnaires. Scores were tested by chi-square.
RESULTSIIEF-5 scores were increased by 42.36% and IPSS scores declined by 20.14%, with statistical significance (P < 0.01).
CONCLUSIONTreatment of ED with Sildenafil appears to improve urinary symptom scores. A lower IPSS at baseline seems to predict a better response to Sildenafil therapy for ED.
